Jennifer Gansert
Impact in
- Oncology top 0.5%
- Colorectal Cancer Treatments and Studies
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 25
- Colorectal Cancer Treatments and Studies 17
- CAR-T cell therapy research 5
- Pancreatic and Hepatic Oncology Research 4
- Cancer Treatment and Pharmacology 4
-
- Lung Cancer Treatments and Mutations 8
- Co-authors
- Kelly S. Oliner (3 shared papers)Lisa Chen (4 shared papers)Igor Puzanov (5 shared papers)Robert H.I. Andtbacka (3 shared papers)Josep Tabernero (4 shared papers)Jean‐Yves Douillard (6 shared papers)David Cunningham (4 shared papers)Salvatore Siena (5 shared papers)
- Journals
- Journal of Clinical Oncology (15 papers)Clinical Cancer Research (3 papers)Annals of Oncology (2 papers)European Journal of Cancer (1 paper)Cell (1 paper)
- Partner nations
- United StatesSpainGermany
In The Last Decade
Jennifer Gansert
30 papers receiving 4.5k citations
Jennifer Gansert's Hit Papers
Peers
Comparison fields: 5 of 89
- Oncology 3.2k
- Hepatology 411
- Immunology 809
- Genetics 852
- Cancer Research 387
Countries citing papers authored by Jennifer Gansert
This map shows the geographic impact of Jennifer Gansert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer Gansert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer Gansert more than expected).
Fields of papers citing papers by Jennifer Gansert
This network shows the impact of papers produced by Jennifer Gansert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer Gansert. The network helps show where Jennifer Gansert may publish in the future.
Co-authors
The 25 scholars most cited alongside Jennifer Gansert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Randomized, Phase III Trial of Panitumumab With Infusional Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX4) Versus FOLFOX4 Alone As First-Line Treatment in Patients With Previously Untreated Metastatic Colorectal Cancer: The PRIME Study Hit paper breakdown → | 2010 | 1355 |
| 2 | Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy Hit paper breakdown → | 2017 | 1165 |
| 3 | Randomized Phase III Study of Panitumumab With Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) Compared With FOLFIRI Alone As Second-Line Treatment in Patients With Metastatic Colorectal Cancer Hit paper breakdown → | 2010 | 756 |
| 4 | Randomized, Open-Label Phase II Study Evaluating the Efficacy and Safety of Talimogene Laherparepvec in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced, Unresectable Melanoma Hit paper breakdown → | 2017 | 482 |
| 5 | 2003 | 148 | |
| 6 | 2013 | 138 | |
| 7 | 2014 | 92 | |
| 8 | 2010 | 77 | |
| 9 | 2009 | 63 | |
| 10 | 2013 | 54 | |
| 11 | 2014 | 36 | |
| 12 | 2009 | 23 | |
| 13 | 2009 | 21 | |
| 14 | 2010 | 20 | |
| 15 | 2009 | 19 | |
| 16 | Randomized Phase 3 Study of Panitumumab With FOLFIRI vs. FOLFIRI Alone as Second-Line Treatment in Patients With Metastatic Colorectal Cancer | 2010 | 18 |
| 17 | 2010 | 15 | |
| 18 | 2014 | 12 | |
| 19 | 2010 | 11 | |
| 20 | 2010 | 9 |
About Jennifer Gansert
Jennifer Gansert is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Genetics and Immunology, having authored 31 papers that have together received 4.5k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (17 papers), Lung Cancer Treatments and Mutations (8 papers), CAR-T cell therapy research (5 papers), Cancer Genomics and Diagnostics (4 papers), Pancreatic and Hepatic Oncology Research (4 papers), Cancer Treatment and Pharmacology (4 papers), Virus-based gene therapy research (4 papers) and Immunotherapy and Immune Responses (3 papers). The work is most often cited by research in Oncology (3.2k citations), Hepatology (411 citations), Immunology (809 citations), Genetics (852 citations) and Cancer Research (387 citations). Jennifer Gansert has collaborated with scholars based in United States, Spain and Germany. Frequent co-authors include Kelly S. Oliner, Lisa Chen, Igor Puzanov, Robert H.I. Andtbacka, Josep Tabernero, Jean‐Yves Douillard, David Cunningham, Salvatore Siena, Mario Barugel and Ronald L. Burkes. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Annals of Oncology, European Journal of Cancer and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.